Health reinsurance's $203 billion structure test

Ceded U.S. health insurance premium reached $203 billion in 2025, up from $59 billion in 2016, according to an AM Best market segment report published Sept. 8, 2026—a $144 billion, roughly 244% increase over the span AM Best calls the past decade, which the report uses to frame reinsurance as a solution that has become more viable for health insurers. The demand side of that framing is easy to accept, but the supply side deserves more scrutiny, since premium totals record how much risk health insurers chose to hand off and little about the terms of the handoff.

Two contracts can contribute the same dollar figure to AM Best's count while carrying entirely different allocations of risk between the reinsurer and the ceding company, and those differences are exactly what will decide whether the line performs. Until the report is read alongside contract terms, the $203 billion is evidence of market activity rather than evidence of sound underwriting.

Reinsurance capital is coming out of a hard market and looking for new places to earn returns, and health reinsurance looks at first glance like a diversifying addition to a book built around catastrophe risk; expansion into a less-tested line is where discipline usually frays, and the growth from $59 billion to $203 billion reflects appetite. Appetite has a way of reading like judgment until losses arrive.

The test that matters now is structural rather than price alone: how much risk is actually transferred, how well the transfer is collateralized, and how losses are allocated when claims deteriorate. Health reinsurance is now large enough to be a case study in that test, and the figures AM Best published describe the size of the experiment but not its design.

The point is to separate adoption from validation. The contracts behind this premium will not prove themselves until a real claims cycle has run, and that evidence is still ahead of the volume. The next ceded-premium total will say how much more risk was sold; the collateral and reserve disclosures that follow will say whether the risk was structured as carefully as it was counted.